elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35050195-8501A44C-A3F5-44EE-90B9-10FFB3A8FE8E
Q35050195-8501A44C-A3F5-44EE-90B9-10FFB3A8FE8E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35050195-8501A44C-A3F5-44EE-90B9-10FFB3A8FE8E
Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab.
P356
Q35050195-8501A44C-A3F5-44EE-90B9-10FFB3A8FE8E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35050195-8501A44C-A3F5-44EE-90B9-10FFB3A8FE8E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
baa26220c56b381126130f6ee4f22153d9b0fd2b
P356
10.1007/S11523-014-0315-Z
http://www.w3.org/2001/XMLSchema#string
P356
S11523-014-0315-Z